Cargando…

Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration

This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE...

Descripción completa

Detalles Bibliográficos
Autores principales: García de la Mària, Cristina, Cervera, Carlos, Pericàs, Juan M., Castañeda, Ximena, Armero, Yolanda, Soy, Dolors, Almela, Manel, Ninot, Salvador, Falces, Carlos, Mestres, Carlos A., Gatell, Jose M., Moreno, Asuncion, Marco, Francesc, Miró, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427314/
https://www.ncbi.nlm.nih.gov/pubmed/25961578
http://dx.doi.org/10.1371/journal.pone.0125818
_version_ 1782370711687397376
author García de la Mària, Cristina
Cervera, Carlos
Pericàs, Juan M.
Castañeda, Ximena
Armero, Yolanda
Soy, Dolors
Almela, Manel
Ninot, Salvador
Falces, Carlos
Mestres, Carlos A.
Gatell, Jose M.
Moreno, Asuncion
Marco, Francesc
Miró, José M.
author_facet García de la Mària, Cristina
Cervera, Carlos
Pericàs, Juan M.
Castañeda, Ximena
Armero, Yolanda
Soy, Dolors
Almela, Manel
Ninot, Salvador
Falces, Carlos
Mestres, Carlos A.
Gatell, Jose M.
Moreno, Asuncion
Marco, Francesc
Miró, José M.
author_sort García de la Mària, Cristina
collection PubMed
description This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE admitted to an 850-bed tertiary care hospital in Barcelona from 1995-2008 were prospectively included in the cohort. We observed that CoNS IE was an important cause of community-acquired and healthcare-associated IE; one-third of patients involved native valves. Staphylococcus epidermidis was the most frequent species, methicillin-resistant in 52% of patients. CoNS frozen isolates were available in 88 patients. Vancomycin MICs of 2.0 μg/mL were common; almost all cases were found among S. epidermidis isolates and did not increase over time. Eighty-five patients were treated either with cloxacillin or vancomycin: 38 patients (Group 1) were treated with cloxacillin, and 47 received vancomycin; of these 47, 27 had CoNS isolates with a vancomycin MIC <2.0 μg/mL (Group 2), 20 had isolates with a vancomycin MIC ≥2.0 μg/mL (Group 3). One-year mortality was 21%, 48%, and 65% in Groups 1, 2, and 3, respectively (P=0.003). After adjusting for confounders and taking Group 2 as a reference, methicillin-susceptibility was associated with lower 1-year mortality (OR 0.12, 95% CI 0.02-0.55), and vancomycin MIC ≥2.0 μg/mL showed a trend to higher 1-year mortality (OR 3.7, 95% CI 0.9-15.2; P=0.069). Other independent variables associated with 1-year mortality were heart failure (OR 6.2, 95% CI 1.5-25.2) and pacemaker lead IE (OR 0.1, 95%CI 0.02-0.51). In conclusion, methicillin-resistant S.epidermidis was the leading cause of CoNS IE, and patients receiving vancomycin had higher mortality rates than those receiving cloxacillin; mortality was higher among patients having isolates with vancomycin MICs ≥2.0 μg/mL.
format Online
Article
Text
id pubmed-4427314
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44273142015-05-21 Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration García de la Mària, Cristina Cervera, Carlos Pericàs, Juan M. Castañeda, Ximena Armero, Yolanda Soy, Dolors Almela, Manel Ninot, Salvador Falces, Carlos Mestres, Carlos A. Gatell, Jose M. Moreno, Asuncion Marco, Francesc Miró, José M. PLoS One Research Article This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE admitted to an 850-bed tertiary care hospital in Barcelona from 1995-2008 were prospectively included in the cohort. We observed that CoNS IE was an important cause of community-acquired and healthcare-associated IE; one-third of patients involved native valves. Staphylococcus epidermidis was the most frequent species, methicillin-resistant in 52% of patients. CoNS frozen isolates were available in 88 patients. Vancomycin MICs of 2.0 μg/mL were common; almost all cases were found among S. epidermidis isolates and did not increase over time. Eighty-five patients were treated either with cloxacillin or vancomycin: 38 patients (Group 1) were treated with cloxacillin, and 47 received vancomycin; of these 47, 27 had CoNS isolates with a vancomycin MIC <2.0 μg/mL (Group 2), 20 had isolates with a vancomycin MIC ≥2.0 μg/mL (Group 3). One-year mortality was 21%, 48%, and 65% in Groups 1, 2, and 3, respectively (P=0.003). After adjusting for confounders and taking Group 2 as a reference, methicillin-susceptibility was associated with lower 1-year mortality (OR 0.12, 95% CI 0.02-0.55), and vancomycin MIC ≥2.0 μg/mL showed a trend to higher 1-year mortality (OR 3.7, 95% CI 0.9-15.2; P=0.069). Other independent variables associated with 1-year mortality were heart failure (OR 6.2, 95% CI 1.5-25.2) and pacemaker lead IE (OR 0.1, 95%CI 0.02-0.51). In conclusion, methicillin-resistant S.epidermidis was the leading cause of CoNS IE, and patients receiving vancomycin had higher mortality rates than those receiving cloxacillin; mortality was higher among patients having isolates with vancomycin MICs ≥2.0 μg/mL. Public Library of Science 2015-05-11 /pmc/articles/PMC4427314/ /pubmed/25961578 http://dx.doi.org/10.1371/journal.pone.0125818 Text en © 2015 García de la Mària et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
García de la Mària, Cristina
Cervera, Carlos
Pericàs, Juan M.
Castañeda, Ximena
Armero, Yolanda
Soy, Dolors
Almela, Manel
Ninot, Salvador
Falces, Carlos
Mestres, Carlos A.
Gatell, Jose M.
Moreno, Asuncion
Marco, Francesc
Miró, José M.
Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
title Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
title_full Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
title_fullStr Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
title_full_unstemmed Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
title_short Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration
title_sort epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427314/
https://www.ncbi.nlm.nih.gov/pubmed/25961578
http://dx.doi.org/10.1371/journal.pone.0125818
work_keys_str_mv AT garciadelamariacristina epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT cerveracarlos epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT pericasjuanm epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT castanedaximena epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT armeroyolanda epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT soydolors epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT almelamanel epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT ninotsalvador epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT falcescarlos epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT mestrescarlosa epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT gatelljosem epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT morenoasuncion epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT marcofrancesc epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT mirojosem epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration
AT epidemiologyandprognosisofcoagulasenegativestaphylococcalendocarditisimpactofvancomycinminimuminhibitoryconcentration